PIK3CG deficiency promotes metabolic reprogramming in pancreatic Cancer by suppressing GLS2-driven glutamine metabolism

International Immunopharmacology 2026

View at publisher
Authors: Lu Han, Die Zhang, Weidong Xiao, Chunyan Zeng, Youxiang Chen
DOI: 10.1016/j.intimp.2025.116106
Cited by: 2
References: 35

Fields of Study & Subjects

Cancer Hypoxia and Metabolism PI3K/AKT/mTOR signaling in cancer Metabolism Diabetes and Cancer

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
172
Pages
116106–116106
Publication date
14 January 2026
Language
EN